Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Novartis AG ADR
0QLRCurrent price
96.61 GBP
-0.85 GBP (-0.88%)
Last closed
106.78 USD
Company
www.novartis.com
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
London Exchange
Capitalization
220 629 532 672 USD
Yield for 12 month
+14.15 %
1Y
3Y
5Y
10Y
15Y
0QLR
Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland. Address: Lichtstrasse 35, Basel, Switzerland, 4056
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
112.46 USDP/E ratio
24.575Dividend Yield
3.49 %Current Year
+46 660 000 000 USD
Last Year
+51 828 000 000 USD
Current Quarter
+11 829 000 000 USD
Last Quarter
+11 776 000 000 USD
Current Year
+34 188 000 000 USD
Last Year
+36 342 000 000 USD
Current Quarter
+8 699 000 000 USD
Last Quarter
+8 754 000 000 USD
Key Figures 0QLR
1 year
3 years
5 years
10 years
EBITDA
18 944 000 000 USD
Operating Margin TTM
PE Ratio
24.575
Return On Assets TTM
8.65 %
PEG Ratio
5.0912
Return On Equity TTM
19.83 %
Wall Street Target Price
112.46 USD
Revenue TTM
47 732 998 144 USD
Book Value
19.45 USD
Revenue Per Share TTM
Dividend Share
3.92 USD
Quarterly Revenue Growth YOY
9.7 %
Dividend Yield
3.49 %
Gross Profit TTM
36 744 000 000 USD
Earnings per share
4.4 USD
Diluted Eps TTM
4.4 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
21.5 %
Profit Margin
31.94 %
Dividend Analytics 0QLR
Dividend growth over 5 years
30 %Continuous growth
1 yearPayout Ratio 5 years average
80 %Dividend History 0QLR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
3.78
Ex Dividend Date
07.03.2024
Forward Annual Dividend Yield
3.49 %
Last Split Factor
1116:1000
Payout Ratio
54.03 %
Last Split Date
09.04.2019
Dividend Date
19.04.2024
Stock Valuation 0QLR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
24.575
Forward PE
13.245
Enterprise Value Revenue
4.4105
Price Sales TTM
4.145
Enterprise Value EBITDA
11.2733
Price Book MRQ
4.0962
Financials 0QLR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0QLR
For 52 weeks
87.56 USD
108.22 USD
50 Day MA
102.82 USD
Shares Short Prior Month
5 129 585
200 Day MA
100.02 USD
Short Ratio
4.88
Shares Short
6 283 959
Short Percent
0.26 %
BeatStart